Companies · NDSN
Nordson
AI-generated · informational only · not investment advice · verify before relying.
Latest analysis
Updated Aug 20, 2026
Nordson delivers all-time record Q3 sales of $818M on 12% organic growth, raises FY2026 guidance as ATS segment surges 31% organically and backlog grows 35% YoY.
Nordson's Q3 FY2026 results mark a clear inflection point: the Advanced Technology Solutions segment posted 31% organic growth and an all-time quarterly sales record of $220M, while Medical and Fluid Solutions hit its own quarterly record at $231M — both segments accelerating beyond prior guidance assumptions. Backlog expanded 35% year-over-year on broad-based order momentum across all three segments, giving management sufficient visibility to raise full-year guidance to $3.035–$3.075B in sales and $11.80–$12.00 in adjusted EPS. EBITDA of $262M at 32% of sales and adjusted EPS of $3.25 both represent company-wide all-time records, with free cash flow conversion of 144% of net income underscoring earnings quality.
Tone: bullishRevenue
$2.8B
NDSN 10-K · FY 2025
Employees
8,000
Revenue FY2024
$2.7B
Founded
1954
Profile
NDSN 10-K Item 1 · Dec 17, 2025Nordson is a diversified precision technology company that engineers, manufactures, and markets systems used for dispensing adhesives, coatings, polymers, sealants, and biomaterials, as well as testing, inspecting, and surface treatment equipment. The company operates across three segments — Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions — serving a broad range of end markets globally. Approximately 67 percent of revenues were generated outside the United States in fiscal 2025.
Read filing description ↓ Collapse description ↑
Nordson is an innovative precision technology company that leverages a scalable growth framework to deliver top tier growth with leading margins and returns. We engineer, manufacture and market differentiated products and systems used for precision dispensing, applying and controlling of adhesives, coatings, polymers, sealants, biomaterials, and other fluids, to test and inspect for quality, and to treat and cure surfaces and various medical products such as: catheters, cannulas, medical balloons and medical tubing. These products are supported with extensive application expertise and direct global sales and service. We serve a wide variety of consumer non-durable, consumer durable and technology end markets including packaging, electronics, medical, appliances, energy, transportation, precision agriculture, building and construction, and general product assembly and finishing. Our strategy for long-term growth is based on solving customers' needs globally. We were incorporated in the State of Ohio in 1954 and are headquartered in Westlake, Ohio. Our products are marketed through a network of direct operations in more than 35 countries. Consistent with this global strategy, approximately 67 percent of our revenues were generated outside the United States in 2025. In 2021, we launched the Ascend strategy, which is designed to deliver top tier revenue growth with leading margins and returns. Ascend is driven by three interconnected pillars: the NBS (Nordson Business System) Next growth framework; Owner Mindset, our division-led organizational structure; and Winning Teams, our talent strategy.
Primary products
- Industrial Coatings
- Nonwovens
- Packaging
- Polymer Processing
- Precision Agriculture
- Product Assembly
Business segments
End markets
Geographies
“We maintain a leadership position in our business segments by delivering high-quality, innovative products and technologies, as well as global service and technical support.” Competitive position, as stated in the filing
The rest of NDSN is for subscribers
Analysis, signals, diligence answers, M&A activity and every quote, each citing the filing it came from.